A growing platform of AI-assisted, reviewer-gated clinical decision-support modules — built by clinicians, audited at every step, published only when a named reviewer signs off.
Built for ENT clinicians, audiology and neurology trainees, and vestibular therapists.
A 65-year-old man presents with continuous spinning vertigo for 6 hours and persistent horizontal nystagmus that beats to the right. What do the three HINTS findings suggest?
Pick one option in each row to see the interpretation.
Today in ENT · 19 Jul 2026
4 peer-reviewed articles from 44 whitelisted ENT journals, AI-scored for clinical relevance and summarised for practising clinicians.
Noninvasive treatments for laryngeal dystonia—including voice therapy, GABAergic modulators, neuromodulation, and complementary therapies—showed limited clinical benefit across 25 studies, with improvements generally small and short-lived. Neuromodulatory approaches showed the most promise but remain constrained by small samples and heterogeneous study designs.
Survival in head and neck neuroendocrine carcinoma varied markedly by site and histology: laryngeal and well-differentiated tumors fared best, while poorly-differentiated and small-cell variants had median OS under 24 months. No treatment guidelines exist, and therapeutic heterogeneity across studies underscores the need for standardized, histology- and site-specific protocols.
Psychophysical taste testing detected dysfunction in over 70% of Bell's palsy patients, far exceeding self-reported rates of 10–60%, with taste deficits often preceding facial weakness, indicating early chorda tympani involvement. Taste function typically recovered within 6 months, but its value as a prognostic marker for motor recovery remains unclear.
Laryngofissure approach enabled NIR-PIT delivery to a subglottic/posterior recurrent laryngeal cancer (cT2N2bM0, post-chemoradiotherapy), achieving larynx preservation in a case where endoscopic light delivery was inaccessible.
Upcoming events · refreshed 12 Jul 2026
8 otorhinolaryngology conferences, workshops and cadaver courses in the next twelve months — international, national and regional, curated weekly by AI from official society sites.
Quadrennial global congress bringing together 70+ member societies for multidisciplinary head and neck cancer care.
World's largest ENT gathering with 10,000+ participants, 53 parallel halls, and AI-powered simultaneous translation.
Independent allergy-focused meeting with didactic sessions, game-based learning, and CME credits meeting ABOTOHNS requirements.
France's premier ENT congress with 2,500+ participants, including multidisciplinary hearing day and nursing sessions.
A clinician-facing decision-support tool for Otolaryngology, derived from the structure of *Decision Making in Otolaryngology* with every node's content freshly synthesised from peer-reviewed literature and reviewer-approved before going live (per ADR 0005). v1 ships Sudden Sensorineural Hearing Loss end-to-end; further chapters expand from there using the same pipeline.
SSNHL · v1 chapter · pipeline 56%
Chapters
Vertigo decision support — coming after the ORL module validates the pipeline.
Nasal allergy decision support — pending Rhino-AI compatibility audit (ADR 0003).
Disclaimer
For educational purposes only. Not for clinical use. This platform is an instructional resource intended to support learning about clinical decision-making and the interpretation of investigations. Clinicians remain completely responsible for the interpretation of findings, the formulation of a differential diagnosis, and any clinical decision. Nothing in this application replaces individualized assessment, hands-on training, expert consultation, or established practice guidelines.
Not for profit effort by
Supporting organisations
